Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Vladimir Milanov"'
Autor:
Nina Yancheva, Dimitar Strashimirov, Daniel Ivanov, Rusina Grozdeva, Elizabeta Bachiyska, Vladimir Milanov
Publikováno v:
International Journal of Mycobacteriology, Vol 13, Iss 1, Pp 112-114 (2024)
Microorganisms belonging to the Mycobacterium avium complex (MAC) are ubiquitous in the environment, but only a minority of infected persons develop disease. An underlying lung disease or immune deficiency is a prerequisite for clinical manifestation
Externí odkaz:
https://doaj.org/article/f9f3738601a54afea96072e2e20c8eb0
Autor:
Yana Todorova, Radoslava Emilova, Vladimir Milanov, Elizabeta Bachiyska, Yuliana Atanasova, Ana Baikova, Maria Nikolova
Publikováno v:
Folia Medica, Vol 65, Iss 3, Pp 399-406 (2023)
Abstract Introduction: The need for biomarkers predicting the course of MTB infection and the necessity of specific therapy are well recognized. Recent data point to the role of cytokines and lipid mediators in protective immunity against tuberculosi
Externí odkaz:
https://doaj.org/article/96725e53de054960acd64700c996a999
Autor:
Vladimir Milanov, Nikolay Yanev, Natalia Gabrovska, Denitsa Dimitrova, Elizabeta Bachiyska, Vania Youroukova
Publikováno v:
Problems of Infectious and Parasitic Diseases, Vol 50, Iss 1 (2022)
Isoniazid (H; INH) is an important first-line drug for the treatment of active tuberculosis (TB) and latent TB infection because of its potent early bactericidal activity against Мycobacterium tuberculosis. Currently, TB resistant to INH, alone or i
Externí odkaz:
https://doaj.org/article/f24b98230524433ca13940910870dfa0
Autor:
Nikolay Yanev, Evgeni Mekov, Dinko Valev, Georgi Yankov, Vladimir Milanov, Stoyan Bichev, Natalia Gabrovska, Dimitar Kostadinov
Publikováno v:
PeerJ, Vol 9, p e11448 (2021)
Background In recent years, there has been a revolution in the genomic profiling and molecular typing of lung cancer. A key oncogene is the epidermal growth factor receptor (EGFR). The gold standard for determining EGFR mutation status is tissue biop
Externí odkaz:
https://doaj.org/article/486a2dc44b954ff39721fda9c2d0ceb2
Autor:
Natalia Gabrovska, Albena Spasova, Anabela Galacheva, Dimitar Kostadinov, Nikolay Yanev, Vladimir Milanov, Kaloyan Gabrovski, Svetlana Velizarova
Publikováno v:
Children, Vol 9, Iss 6, p 785 (2022)
Background: Each year, approximately two million adolescents and young adults in the world become infected with tuberculosis (TB). The problem is that the classification of the disease includes children in the age group 0–14 years and young adults
Externí odkaz:
https://doaj.org/article/f81b93da169b4a7b947e2a403246f6f2
Autor:
Yana Todorova, Radoslava Emilova, Vladimir Milanov, Lilia Eneva, Elizabeta Bachiyska, Yuliana Atanasova, Ana Baykova, Maria Nikolova
Publikováno v:
Problems of Infectious and Parasitic Diseases, Vol 47, Iss 1 (2019)
Last generation IFN gamma – based assays (IGRAs) evaluate bulk CD4 and CD8 T cell responses, and do not discriminate between latent and active Micobacterium tuberculosis (MTB) infection. The identification of biomarkers predicting the clinical cour
Externí odkaz:
https://doaj.org/article/3d1ea05e5ff9475e9f636ef086924fd9
Publikováno v:
Problems of Infectious and Parasitic Diseases, Vol 47, Iss 1 (2019)
Tuberculosis has a greater impact on morbidity and mortality in HIV-1-infected individuals than the rest of the opportunistic infections. We report a case of 57-year-old HIV-infected patient co-infected with multidrug- resistant tuberculosis (MDR-TB)
Externí odkaz:
https://doaj.org/article/034536297ee745389ada14c0f6a7f0b8
Autor:
Vladimir Milanov, Dennis Falzon, Mariya Zamfirova, Tonka Varleva, Elizabeta Bachiyska, Antoniya Koleva, Masoud Dara
Publikováno v:
International Journal of Mycobacteriology, Vol 4, Iss 2, Pp 131-137 (2015)
Objective: To analyze determinants of success and death in multidrug-resistant tuberculosis patients (MDR-TB; resistance to, at least, isoniazid and rifampicin) placed on treatment in Bulgaria during the period September 2009 to March 2010 using logi
Externí odkaz:
https://doaj.org/article/9410f279c1c94906ac5ba7cbd2e28be7
Publikováno v:
Proceedings of the Bulgarian Academy of Sciences. 75:1351-1355
Smoking as a cause of cancer development has been the subject of research by the International Agency for Research on Cancer (IARC) [1, 2]. The highest rates are for lung (up to 90% of cases), oral cavity (92%) and larynx (87%) cases [3]. Smoking is
Autor:
Ana Baykova, Yana Todorova, Radoslava Emilova, Maria Nikolova, Elizabeta Bachiyska, Vladimir Milanov, Yuliana Atanasova
Publikováno v:
Tuberculosis and non-tuberculous mycobacterial diseases.